1-15 of 447
Steroidal vs Nonsteroidal MRAs: Implications for Heart Failure Care
Heart MattersSteroidal vs Nonsteroidal MRAs: Implications for Heart Failure Care
Steve Jackson, PharmD
Robert J. Mentz, MD, FHFSA, FACC
Steve Jackson, PharmD
Robert J. Mentz, MD, FHFSA, FACC
“We have the opportunity to understand what happens when someone leaves the clinic,” says Dr. Rajiv Kumar of Apple and Stanford Medicine
The Convergence“We have the opportunity to understand what happens when someone leaves the clinic,” says Dr. Rajiv Kumar of Apple and Stanford Medicine
Brian P. McDonough, MD, FAAFP
Rajiv Kumar, MD
Integrating Weight Management Into Comprehensive Asthma Care
Clinician's RoundtableIntegrating Weight Management Into Comprehensive Asthma Care
Anne Dixon, MD
Obesity and Asthma: Intersecting Pathways and Real-World Impacts
Clinician's RoundtableObesity and Asthma: Intersecting Pathways and Real-World Impacts
Anne Dixon, MD
MASLD and MASH in Focus: Clinical Priorities and Promising Pathways
Clinician's RoundtableMASLD and MASH in Focus: Clinical Priorities and Promising Pathways
Peter Buch, MD, FACG, AGAF, FACP
- advertisement
The Metabolic Roots of Early-Onset Colorectal Cancer
Project Oncology®The Metabolic Roots of Early-Onset Colorectal Cancer
MASLD Explained: A Modern Framework for a Multisystem Condition
Clinician's RoundtableMASLD Explained: A Modern Framework for a Multisystem Condition
Peter Buch, MD, FACG, AGAF, FACP
Unveiling the Role of Obesity in MASLD Progression
Clinician's RoundtableUnveiling the Role of Obesity in MASLD Progression
New Insights into VKD: Exploring Maternal Obesity and Neonatal Vitamin K Status
Clinician's RoundtableNew Insights into VKD: Exploring Maternal Obesity and Neonatal Vitamin K Status
From Gut Microbe to Metabolic Modulator: The Potential Role of R. hominis in Obesity
Clinician's RoundtableFrom Gut Microbe to Metabolic Modulator: The Potential Role of R. hominis in Obesity
Hallie Blevins, PhD
Assessing the Role of Metabolic Factors in Psoriasis Management
AudioAbstractsAssessing the Role of Metabolic Factors in Psoriasis Management
Ryan Quigley
- advertisement
Finerenone for CKD in Type 1 Diabetes: Updates from FINE-ONE
Heart MattersFinerenone for CKD in Type 1 Diabetes: Updates from FINE-ONE
Janet B. McGill, MD, MA, FACE, FACP
Finerenone vs Placebo in Type 1 Diabetes and CKD: Updates From the Phase 3 FINE-ONE Trial From the Kidney Meeting 2025 in Houston
NephrologyFinerenone vs Placebo in Type 1 Diabetes and CKD: Updates From the Phase 3 FINE-ONE Trial From the Kidney Meeting 2025 in Houston
prof. Hiddo Heerspink
Implications of the FINE-ONE Trial: How Might Recently Presented Data From the 2025 Kidney Meeting Influence the Current Treatment Paradigm for Type 1 Diabetes and CKD?
NephrologyImplications of the FINE-ONE Trial: How Might Recently Presented Data From the 2025 Kidney Meeting Influence the Current Treatment Paradigm for Type 1 Diabetes and CKD?
Richard E. Pratley, MD
